Detalhe da pesquisa
1.
Management of patients with germline predisposition to haematological malignancies considered for allogeneic blood and marrow transplantation: Best practice consensus guidelines from the UK Cancer Genetics Group (UKCGG), CanGene-CanVar, NHS England Genomic Laboratory Hub (GLH) Haematological Malignancies Working Group and the British Society of Blood and Marrow Transplantation and cellular therapy (BSBMTCT).
Br J Haematol
; 201(1): 35-44, 2023 04.
Artigo
Inglês
| MEDLINE | ID: mdl-36786081
2.
Classification and Personalized Prognosis in Myeloproliferative Neoplasms.
N Engl J Med
; 379(15): 1416-1430, 2018 10 11.
Artigo
Inglês
| MEDLINE | ID: mdl-30304655
3.
Mutant calreticulin knockin mice develop thrombocytosis and myelofibrosis without a stem cell self-renewal advantage.
Blood
; 131(6): 649-661, 2018 02 08.
Artigo
Inglês
| MEDLINE | ID: mdl-29282219
4.
Effect of mutation order on myeloproliferative neoplasms.
N Engl J Med
; 372(7): 601-612, 2015 Feb 12.
Artigo
Inglês
| MEDLINE | ID: mdl-25671252
5.
Molecular determinants of pathogenesis and clinical phenotype in myeloproliferative neoplasms.
Haematologica
; 102(1): 7-17, 2017 01.
Artigo
Inglês
| MEDLINE | ID: mdl-27909216
6.
PTCH1 expression at diagnosis predicts imatinib failure in chronic myeloid leukaemia patients in chronic phase.
Am J Hematol
; 90(1): 20-6, 2015 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-25250944
7.
Increased CXCL10 (IP-10) associates with advanced myeloproliferative neoplasms and its loss dampens erythrocytosis in mouse models.
Exp Hematol
; : 104246, 2024 May 17.
Artigo
Inglês
| MEDLINE | ID: mdl-38763471
8.
A common novel splice variant of SLC22A1 (OCT1) is associated with impaired responses to imatinib in patients with chronic myeloid leukaemia.
Br J Haematol
; 163(5): 631-9, 2013 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-24117365
9.
DNMT3A mutations occur early or late in patients with myeloproliferative neoplasms and mutation order influences phenotype.
Haematologica
; 100(11): e438-42, 2015 Nov.
Artigo
Inglês
| MEDLINE | ID: mdl-26250577
10.
Association of FcγRIIa R131H polymorphism with idiopathic pulmonary fibrosis severity and progression.
BMC Pulm Med
; 10: 51, 2010 Oct 07.
Artigo
Inglês
| MEDLINE | ID: mdl-20929558
11.
Prognostic models in the myeloproliferative neoplasms.
Blood Rev
; 42: 100713, 2020 07.
Artigo
Inglês
| MEDLINE | ID: mdl-32532453
12.
Mutant Calreticulin in the Myeloproliferative Neoplasms.
Hemasphere
; 4(1): e333, 2020 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-32382708
13.
Longitudinal Cytokine Profiling Identifies GRO-α and EGF as Potential Biomarkers of Disease Progression in Essential Thrombocythemia.
Hemasphere
; 4(3): e371, 2020 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-32647796
14.
Methylation age as a correlate for allele burden, disease status, and clinical response in myeloproliferative neoplasm patients treated with vorinostat.
Exp Hematol
; 79: 26-34, 2019 11.
Artigo
Inglês
| MEDLINE | ID: mdl-31563618
15.
The peripheral blood features of acute myeloid leukemia with inv(16)(p13.1q22).
Am J Hematol
; 88(11): 975, 2013 Nov.
Artigo
Inglês
| MEDLINE | ID: mdl-23897678
16.
Hydroxycarbamide Plus Aspirin Versus Aspirin Alone in Patients With Essential Thrombocythemia Age 40 to 59 Years Without High-Risk Features.
J Clin Oncol
; 36(34): 3361-3369, 2018 12 01.
Artigo
Inglês
| MEDLINE | ID: mdl-30153096
17.
After 10years of JAK2V617F: Disease biology and current management strategies in polycythaemia vera.
Blood Rev
; 31(3): 101-118, 2017 05.
Artigo
Inglês
| MEDLINE | ID: mdl-27884555
18.
Pathogenesis of Myeloproliferative Disorders.
Annu Rev Pathol
; 11: 101-26, 2016 05 23.
Artigo
Inglês
| MEDLINE | ID: mdl-27193452
19.
MicroRNA-101 expression is associated with JAK2V617F activity and regulates JAK2/STAT5 signaling.
Leukemia
; 32(8): 1826-1830, 2018 08.
Artigo
Inglês
| MEDLINE | ID: mdl-29483713
20.
Update and critical appraisal of sevelamer in the management of chronic renal failure.
Open Access J Urol
; 2: 161-70, 2010 Sep 02.
Artigo
Inglês
| MEDLINE | ID: mdl-24198624